EQUITY RESEARCH MEMO

Pyramid Pharma Services

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)65/100

Pyramid Pharma Services is a US-based Contract Development and Manufacturing Organization (CDMO) headquartered in San Diego, California, specializing in aseptic fill-finish and development services for injectable drugs. Founded in 2015, the company supports biologic, peptide, and small molecule programs from pre-clinical formulation through commercial manufacturing, offering formulation development, analytical testing, and sterile manufacturing into vials and syringes. As a private CDMO, Pyramid Pharma Services is well-positioned to capitalize on the growing demand for outsourced sterile injectable manufacturing, driven by the increasing complexity of biologics and the need for high-quality aseptic processing. The company's end-to-end service model and focus on quality and compliance make it a reliable partner for pharmaceutical sponsors seeking to accelerate drug development and commercialization timelines.

Upcoming Catalysts (preview)

  • TBDCapacity expansion or new facility announcement50% success
  • TBDStrategic partnership with a major pharmaceutical company40% success
  • TBDClient product achieving FDA approval or key regulatory milestone60% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)